Abstract
TCR-β Repertoire as a Source of Biomarkers for anti-PD1 Treatment Alone or in Combination With Chemotherapy in Advanced-stage NSCLC Patients
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
